Evotec SE (EVO) Net Margin (2009 - 2025)
Evotec SE (EVO) reported Net Margin of 40822.22% for Q4 2025, up 4773023.0% on a YoY basis from N/an in Q4 2024, and down 156093.38% sequentially from 26.14% in Q3 2025.
Evotec SE (EVO) Net Margin (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 9 years of Net Margin data on file, last reported at 40822.22% in Q4 2025.
- For the quarter ending Q4 2025, Net Margin rose 4773023.0% year-over-year to 40822.22%; the trailing twelve-month figure through Dec 2025 stood at 13005.66% (up 338680.0% YoY), and the FY2025 full-year result was 13.13%, up 2460211987.0% from the prior year.
- Net Margin fell to 40822.22% in Q4 2025, from 26.14% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 49949.3% in Q4 2021 to a low of 88552.45% in Q4 2024.
- A 5-year average of 8547.36% and a median of 16.22% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin jumped 4820904 bps in 2021 and plunged 8436934 bps in 2022, its largest moves.
- Tracing EVO's Net Margin over 5 years: stood at 49949.3% in 2021, then tumbled by 169 bps to 34420.04% in 2022, then jumped by 58 bps to 14457.12% in 2023, then tumbled by 513 bps to 88552.45% in 2024, then jumped by 54 bps to 40822.22% in 2025.
- Business Quant data shows EVO's Net Margin at 40822.22% in Q4 2025, 26.14% in Q3 2025, and 88552.45% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40,822.22% |
| Sep 30, 2025 | -26.14% |
| Dec 31, 2024 | -88,552.45% |
| Sep 30, 2024 | -29.27% |
| Dec 31, 2023 | -14,457.12% |
| Sep 30, 2023 | 19.85% |
| Jun 30, 2023 | -5.97% |
| Dec 31, 2022 | -34,420.04% |
| Sep 30, 2022 | 27.19% |
| Jun 30, 2022 | -16.22% |
| Mar 31, 2022 | -44.48% |
| Dec 31, 2021 | 49,949.30% |
| Sep 30, 2021 | 84.10% |
| Jun 30, 2021 | 43.42% |
| Mar 31, 2021 | 39.60% |
| Dec 31, 2020 | 1,740.26% |
| Dec 31, 2019 | 8.55% |
| Sep 30, 2010 | 951.73% |
| Jun 30, 2010 | 783.19% |
| Mar 31, 2010 | 0.00% |